Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Asparagine Synthetase Marks a Distinct Dependency Threshold for Cardiomyocyte Dedifferentiation.
Zhu Y, Ackers-Johnson M, Shanmugam MK, Pakkiri LS, Drum CL, Chen Y, Kim J, Paltzer WG, Mahmoud AI, Wen Tan WL, Lee MCJ, Jiang J, Luu DAT, Ng SL, Li PYQ, Wang A, Qi R, Ong GJX, Ng Yu T, Haigh JJ, Tiang Z, Richards AM, Foo R. Zhu Y, et al. Circulation. 2024 Apr 8. doi: 10.1161/CIRCULATIONAHA.123.063965. Online ahead of print. Circulation. 2024. PMID: 38586957
Prospective diagnostic accuracy study of history taking and physical examination for adults with vertigo in general practice: study protocol.
Ross A, Leemeyer AR, Bruintjes TD, Cals JWL, Bronstein A, van Leeuwen RB, Lissenberg-Witte B, van Vugt VA, Rutgers S, Maarsingh OR. Ross A, et al. BMJ Open. 2024 Apr 2;14(4):e085715. doi: 10.1136/bmjopen-2024-085715. BMJ Open. 2024. PMID: 38569697 Free PMC article.
More than 80% of patients with vertigo are primarily treated by their general practitioner (GP) and are never referred to a medical specialist. Despite this therapeutic responsibility, the GP's diagnostic toolkit has serious limitations. ...
More than 80% of patients with vertigo are primarily treated by their general practitioner (GP) and are never referred to a medical s …
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study.
Cameli P, Aliani M, Altieri E, Bracciale P, Brussino L, Caiaffa MF, Canonica GW, Caruso C, Centanni S, D'Amato M, De Michele F, Del Giacco S, Di Marco F, Pelaia G, Rogliani P, Romagnoli M, Schino P, Schroeder JW, Senna G, Vultaggio A, Benci M, Boarino S, Menzella F. Cameli P, et al. J Asthma Allergy. 2024 Mar 27;17:273-290. doi: 10.2147/JAA.S438981. eCollection 2024. J Asthma Allergy. 2024. PMID: 38562251 Free PMC article.
Geochemical Evaluation of Paleocene Source Rocks in the Kohat Sub-Basin, Pakistan.
Sohail J, Mehmood S, Jahandad S, Ehsan M, Abdelrahman K, Ali A, Qadri SMT, Fnais MS. Sohail J, et al. ACS Omega. 2024 Mar 15;9(12):14123-14141. doi: 10.1021/acsomega.3c09457. eCollection 2024 Mar 26. ACS Omega. 2024. PMID: 38559993 Free PMC article.
The thermal maturity of the Hangu and Lockhart formations falls in the late-stage oil window, while that of the Patala formation falls in the peak to late oil window. The genetic potential (GP) for these rock units is also determined based on S(1) and S(2) values, which re …
The thermal maturity of the Hangu and Lockhart formations falls in the late-stage oil window, while that of the Patala formation falls in th …
Design, synthesis and bioactivity study on oxygen-heterocyclic-based pyran analogues as effective P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
Abd El-Wahab AHF, Borik RMA, Al-Dies AM, Fouda AM, Mohamed HM, El-Eisawy RA, Mora A, El-Nassag MAA, Abd Elhady AM, Elhenawy AA, El-Agrody AM. Abd El-Wahab AHF, et al. Sci Rep. 2024 Mar 31;14(1):7589. doi: 10.1038/s41598-024-56197-w. Sci Rep. 2024. PMID: 38555345 Free PMC article.
P-glycoprotein (P-gp) imparts multi-drug resistance (MDR) on the cancers cell and malignant tumor clinical therapeutics. ...The Rho123 accumulation assay showed that compounds 4a-c adequately inhibited P-gp function, as predicted. Furthermore, 4a or 4b administratio …
P-glycoprotein (P-gp) imparts multi-drug resistance (MDR) on the cancers cell and malignant tumor clinical therapeutics. ...The Rho12 …
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.
Mauro FR, Scalzulli PR, Scarfò L, Minoia C, Murru R, Sportoletti P, Frigeri F, Albano F, Di Renzo N, Sanna A, Laurenti L, Massaia M, Cassin R, Coscia M, Patti C, Pennese E, Tafuri A, Chiarenza A, Galieni P, Perbellini O, Selleri C, Califano C, Ferrara F, Cuneo A, Murineddu M, Palumbo G, Scortechini I, Tedeschi A, Trentin L, Varettoni M, Pane F, Liberati AM, Merli F, Morello L, Musuraca G, Tani M, Ibatici A, Regazzoni G, Di Candia M, Palma M, Arienti D, Molica S. Mauro FR, et al. Cancers (Basel). 2024 Mar 20;16(6):1228. doi: 10.3390/cancers16061228. Cancers (Basel). 2024. PMID: 38539561 Free PMC article.
4,356 results